iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
107.74
-2.60 (-2.36%)
Jan 30, 2025, 4:00 PM EST - Market closed
iRhythm Technologies Revenue
iRhythm Technologies had revenue of $147.54M in the quarter ending September 30, 2024, with 18.41% growth. This brings the company's revenue in the last twelve months to $560.03M, up 18.45% year-over-year. In the year 2023, iRhythm Technologies had annual revenue of $492.68M with 19.90% growth.
Revenue (ttm)
$560.03M
Revenue Growth
+18.45%
P/S Ratio
6.11
Revenue / Employee
$280,013
Employees
2,000
Market Cap
3.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 492.68M | 81.76M | 19.90% |
Dec 31, 2022 | 410.92M | 88.10M | 27.29% |
Dec 31, 2021 | 322.83M | 57.66M | 21.74% |
Dec 31, 2020 | 265.17M | 50.61M | 23.59% |
Dec 31, 2019 | 214.55M | 67.28M | 45.68% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.95B |
IRTC News
- 16 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Shareholders to Inquire about Securities Investigation - Accesswire
- 17 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect - Accesswire
- 17 days ago - iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 18 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out - Accesswire
- 20 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 21 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation - Accesswire
- 22 days ago - iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 23 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect - Accesswire